Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) CIO Vikas Gupta purchased 11,500 shares of the firm’s stock in a transaction on Thursday, November 6th. The stock was acquired at an average price of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the transaction, the executive directly owned 13,773 shares of the company’s stock, valued at approximately $591,825.81. This trade represents a 505.94% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Omega Healthcare Investors Trading Up 2.1%
Shares of OHI stock opened at $43.54 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. The company has a market cap of $12.87 billion, a price-to-earnings ratio of 26.88, a PEG ratio of 1.85 and a beta of 0.69. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $43.62. The firm has a fifty day moving average price of $41.52 and a 200-day moving average price of $39.27.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. During the same period in the previous year, the business earned $0.71 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. As a group, equities analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.
Omega Healthcare Investors Dividend Announcement
Institutional Investors Weigh In On Omega Healthcare Investors
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 3.4% in the 3rd quarter. Vanguard Group Inc. now owns 42,152,368 shares of the real estate investment trust’s stock worth $1,779,673,000 after purchasing an additional 1,386,887 shares during the period. State Street Corp increased its position in Omega Healthcare Investors by 4.8% during the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after acquiring an additional 671,473 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Omega Healthcare Investors by 4.6% in the second quarter. Geode Capital Management LLC now owns 7,377,761 shares of the real estate investment trust’s stock valued at $270,426,000 after acquiring an additional 326,595 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Omega Healthcare Investors by 2.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 4,201,353 shares of the real estate investment trust’s stock worth $153,980,000 after acquiring an additional 100,462 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after purchasing an additional 165,554 shares during the period. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts have commented on OHI shares. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective for the company. Truist Financial boosted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research report on Wednesday, September 3rd. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Finally, Scotiabank increased their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $44.29.
View Our Latest Analysis on Omega Healthcare Investors
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories
- Five stocks we like better than Omega Healthcare Investors
- Buy P&G Now, Before It Sets A New All-Time High
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- How to Calculate Stock Profit
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Utilities Stocks Explained – How and Why to Invest in Utilities
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
